| Absorption |
| Blood-Brain Barrier | BBB+ | 0.5705 |
| Human Intestinal Absorption | HIA+ | 0.8472 |
| Caco-2 Permeability | Caco2- | 0.7378 |
| P-glycoprotein Substrate | Substrate | 0.5369 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9437 |
| Non-inhibitor | 0.9657 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9194 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6897 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8119 |
| CYP450 2D6 Substrate | Non-substrate | 0.9111 |
| CYP450 3A4 Substrate | Non-substrate | 0.6915 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.7367 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8076 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9467 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9208 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8800 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8757 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9736 |
| Non-inhibitor | 0.8978 |
| AMES Toxicity | Non AMES toxic | 0.8599 |
| Carcinogens | Non-carcinogens | 0.9569 |
| Fish Toxicity | High FHMT | 0.9476 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9710 |
| Honey Bee Toxicity | High HBT | 0.6589 |
| Biodegradation | Not ready biodegradable | 0.6562 |
| Acute Oral Toxicity | II | 0.5589 |
| Carcinogenicity (Three-class) | Non-required | 0.6214 |